Antiverse

Developer of computational platform for de novo design of antibody therapeutics

placeCardiff, Wales, United Kingdom calendar_todayFounded 2017 groups7 employees language antiverse.io

Registered entities

Social engagement

Social engagement: 5.7K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

36 investors on record; lead investors include Development Bank of Wales, ACF Investors, Tensor Ventures, Wren Capital.

Investor typeCountShare
Venture capital1336%
Private equity38%
Angel & family office13%
Accelerator & incubator26%
Other / undisclosed1747%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

1 Apr 2026 · VP of Business Development and Licensing, VP of Antibody Development, Antibody Discovery Scientist, Computatio · Boston (Hybrid)

30 Mar 2026 · Senior Machine Learning Engineer

Based on job postings tracked across public sources.

Recent activity

20 May 2026
Event
The Future of Drug Discovery podcast
Coming soon